Picture of IntegraGen SA logo

ALINT — IntegraGen SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: IntegraGen FY Revenue At EUR 12.6 Mln

Jan 13 (Reuters) - INTEGRAGEN SA  ALINT.PA :
    * INTEGRAGEN REPORTS €12.6M IN REVENUES FOR 2022
REPRESENTING 16%
GROWTH COMPARED TO 2021 AND A CASH POSITION OF €4.5M
    * GROWTH SUPPORTED BY HIGH-THROUGHPUT GENOMIC SEQUENCING
LABORATORY IN EVRY
    * CONFIRMS ITS GROWTH PERSPECTIVES BASED ON CURRENT SALES
DYNAMICS
AND EXISTING LONG-TERM CONTRACTS ALONG WITH SYNERGIES NOW IN
PLACE WITHIN ONCODNA GROUP

Source text for Eikon:  ID:nBw4NfK98a 
Further company coverage:  ALINT.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))

Recent news on IntegraGen SA

See all news